Medical Cannabis on NHS: Scotland Pilot Programme Results
Results from a Scottish NHS pilot programme providing medical cannabis to selected patients have shown promising outcomes, with participants reporting significant reductions in pain and improvements in sleep.
A pilot programme conducted within the Scottish NHS has published initial results from its evaluation of medical cannabis prescribing for patients with chronic, treatment-resistant conditions. The programme — one of the first formally NHS-administered medical cannabis initiatives in the UK — represents an important test case for the feasibility of broader NHS provision.
Programme Overview
The Scottish pilot enrolled patients with moderate-to-severe chronic pain who had not achieved adequate relief from conventional analgesics including strong opioids. Participants received standardised cannabis-based medicinal products through NHS channels at no direct cost, with outcomes tracked against validated clinical instruments over a six-month follow-up period.
Key Results
- 68% of participants reported clinically meaningful reductions in pain severity scores
- 72% reported improvement in sleep quality by week eight
- 54% were able to reduce their opioid dose by at least 25% during the programme period
- Patient-reported quality of life measures improved significantly across multiple domains
- Adverse effects were generally mild and consistent with known cannabis medicine profiles
Significance for NHS Access
The programme's results are likely to feature prominently in ongoing advocacy efforts for broader NHS reimbursement of medical cannabis. Currently, the only NHS-funded cannabis medicines available are Sativex for multiple sclerosis spasticity and Epidyolex for certain forms of childhood epilepsy.
Proponents argue that the Scottish pilot demonstrates the feasibility of NHS administration of cannabis medicines beyond these narrow indications, and that the cost-benefit analysis becomes favourable when the reduction in opioid prescribing and associated harms is taken into account.
What Patients in Scotland Can Do Now
While the pilot programme is closed to new enrolments, Scottish patients can access medical cannabis through the same private clinic route available across the rest of the UK. Our clinic directory includes providers accepting patients from all parts of the UK, including Scotland. If you are interested in the evidence for cannabis and chronic pain, our condition pages provide detailed information on the research landscape.
